4:00–8:00 PM | Registration |
7:30–8:30 AM | Breakfast |
8:00–8:30 AM | Poster Setup |
8:15–5:00 PM | Poster Viewing |
8:30–9:30 AM | Welcome and Keynote Address |
Simon Richards, Isomorphic Labs Development and Application of an AI-First Drug Design Platform at Isomorphic Labs |
9:30–11:45 AM | Computation Methods in Structure-Based Small Molecule Design |
Christina Schindler, Merck KGaA Computational Drug Design across Different Modalities |
Vineet Pande, Johnson & Johnson Innovative Medicine Computational Advances in Discovering Cryptic Pockets for Drug Discovery |
Heidi Koldsoe, Scorpion Therapeutics Drugging the Undruggable: Leveraging Computational Techniques to Drive Compound Design |
Short Talk(s) Chosen from Abstracts |
10:00–10:20 AM | Coffee Break |
11:45–12:45 PM | Lunch |
12:30–2:30 PM | Poster Session 1 |
2:30–4:30 PM | Symposia Spotlight 1: Late-breaking research presentations selected from abstract submissions |
Short Talk(s) Chosen from Abstracts |
4:30–5:00 PM | Coffee Available |
5:00–7:00 PM | Computational Methods in Protein Therapeutic Design |
Christian Stegmann, Absci Harnessing Generative AI to Creation and Development of ABS-201: A Novel Anti-PRLR Antibody for Androgenic Alopecia |
Bingxu Liu, University of Washington Peptide-MHCI (pMHCI) Binder Design |
Sebastian Kelm, UCB Pharma in silico Antibody Design |
Short Talk(s) Chosen from Abstracts |
7:00–8:00 PM | On Own for Dinner |
7:30–8:30 AM | Breakfast |
8:30–11:30 AM | AI-based Acceleration of Multi-Omics Advances in Cell Biology |
Daniel J. Anderson, Eikon Therapeutics Single Molecule Tracking in Drug Discovery and Systems Biology |
Richard Bonneau, Genentech Avoiding Funnels: Using Active Learning and Generative AI to Drive Drug Discovery |
Ben Lehner, Wellcome Sanger Institute Complete Allosteric Maps for Drug Discovery |
Short Talk(s) Chosen from Abstracts |
9:30–9:50 AM | Coffee Break |
11:00–1:00 PM | Poster Setup |
11:30–12:30 PM | Lunch |
12:30–2:30 PM | Poster Session 2 |
1:00–10:00 PM | Poster Viewing |
2:30–4:30 PM | Symposia Spotlight 2: Late-breaking research presentations selected from abstract submissions |
Short Talk(s) Chosen from Abstracts |
3:30–4:30 PM | Career Roundtable |
4:30–5:00 PM | Coffee Available |
5:00–7:00 PM | Advances in Predictive Toxicology Methods |
Blanca Rodriguez, University of Oxford Digital Twins and In Silico Clinical Trials for Drug Discovery |
Friedemann Schmidt, Sanofi Decoding Toxicology: Computational Frameworks for Next-Generation Predictive Safety |
Henrik Renner, Evotec SE Human iPSC High-throughput Screening for Teratogenicity Hazard Identification |
Short Talk(s) Chosen from Abstracts |
7:00–8:00 PM | On Own for Dinner |
7:30–8:30 AM | Breakfast |
8:30–11:30 AM | Machine Learning Applications in Translational Science |
Tali Raveh-Sadka, Immunai Identification of High Confidence Candidate Markers for Macrophage Infiltrating Tumor Microenvironment Through Single Cell Genomic Atlases |
Bissan Al-Lazikani, University of Texas MD Anderson Cancer Center The Kinase Polypharmacology Landscape of Clinical PARP Inhibitors |
Gayle Wittenberg, Janssen R&D, LLC A Multimodal Digital Biomarker of Functional Deficits in Early‐Stage Alzheimer’s Disease |
Short Talk(s) Chosen from Abstracts |
9:30–9:50 AM | Coffee Break |
11:30–12:30 PM | Lunch |
2:30–4:30 PM | Panel: Opportunities and Challenges in Computational Drug Discovery and Development? |
* Karen Akinsanya, Schrödinger |
Najat Khan, Recursion Pharmaceuticals |
Alexander Hillisch, UCB BioSciences GmbH |
Richard Bonneau, Genentech |
4:30–5:00 PM | Coffee Available |
5:00–6:45 PM | AI Application in Global Health Drug Discovery |
Jonathan E Gable, Novartis Biomedical Research Diverse Application of AI in Drug Discovery at Novartis |
Jinjiang Guo, Global Health Drug Discovery Institute Generative AI-Enabled Multi-Parameter Lead Optimization in Early Drug Discovery |
Short Talks Chosen from Abstracts |
6:45–7:00 PM | Meeting Wrap-Up: Outcomes and Future Directions (Organizers) |
7:00–8:00 PM | On Own for Dinner |
12:00–11:59 PM | Departure |